AngioDynamics Reports Fiscal Year 2025 First Quarter Financial Results

Stock Information for AngioDynamics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About AngioDynamics Inc.

AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation
AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System
AngioDynamics Announces American Medical Association's CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and Liver
AngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18?? System in Treatment of Pulmonary Embolism and Long-Term Functional Outcomes
AngioDynamics to Report Fiscal 2025 First Quarter Financial Results on October 3, 2024
AngioDynamics Announces CE Mark Approval in Europe for the Auryon System
AngioDynamics to Participate in Upcoming Investor Conferences
AngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.